Banner

First drug-eluting contact lens approved in Japan

Video

Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses.

Acuvue Theravision with Ketotifen from Johnson & Johnson Vision is the first entry into an anticipated category of drug-eluting contact lenses. This lens was recently approved in Japan for vision correction and allergy symptom relief. Brian Pall, OD, MS, FAAO, director of clinical science at Johnson & Johnson Vision Care, discusses the lens and its technology.

Related Videos
The ins and outs of fitting multifocal contact lenses with Dr Jessica Crooker
Marjorie Rah, OD, PhD, FAAO
Clark Chang, OD, MSA, MSc, FAAO
Jamie Kuzniar, OD, presented at IKA Keratoconus Symposium
John D. Gelles, OD, FAAO, FIAOMIC, FCLSA, FSLS, and Steven A. Greenstein, MD, at IKA Keratoconus Symposium 2023
© 2023 MJH Life Sciences

All rights reserved.